Literature DB >> 30302430

Symptomatic hepatic metastasis of insulinoma 15 years after pancreatic resection.

Samet Yardımcı1, İlter Özer2, Tahsin Dalgıç2, Nesrin Turhan3, Erdal Birol Bostancı2.   

Abstract

Malignant insulinomas are infrequent endocrine tumors with miscellaneous clinical courses. In this report, we present a rare case of insulinoma that recurred with solitary hepatic metastasis 15 years after the initial resection of the primary tumor from the pancreas. A 20-year-old woman first presented with the symptoms of hypoglycemia in 1996. The diagnosis of pancreatic insulinoma was confirmed by laboratory findings, and the initial surgery had been performed involving complete enucleation of the pancreatic mass. Histopathologically, the tumor was diagnosed as a benign adenoma. After 15 years, the patient experienced symptoms of hypoglycemia again, and laboratory findings and abdominal computed tomography identified a lesion in the liver. Intraoperative ultrasound did not show any lesion in the pancreas, and wedge resection was performed for the hepatic lesion. Postoperative blood glucose levels returned to normal. Histopathologic examination confirmed the diagnosis of liver metastasis of a neuroendocrine tumor. This is the longest interval between primary tumor and the metastasis reported in the literature, for insulinoma. Thus, it should be remembered that long-term follow-up is mandatory for the patients with insulinoma even after resection of the primary tumor. Resection is recommended when a metastatic lesion is observed.

Entities:  

Keywords:  Insulinoma; liver; metastasis; pancreas

Year:  2018        PMID: 30302430      PMCID: PMC6173605          DOI: 10.5152/turkjsurg.2017.3276

Source DB:  PubMed          Journal:  Turk J Surg        ISSN: 2564-6850


  9 in total

Review 1.  Pancreatic neuroendocrine tumors: overview of recent advances and diagnosis.

Authors:  Robert T Jensen
Journal:  J Gastrointest Surg       Date:  2006-03       Impact factor: 3.452

Review 2.  Pancreatic insulinoma: current issues and trends.

Authors:  Dennis Vaidakis; John Karoubalis; Theodora Pappa; George Piaditis; George N Zografos
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2010-06

Review 3.  A systematic review of localization, surgical treatment options, and outcome of insulinoma.

Authors:  Arianeb Mehrabi; Lars Fischer; Mohammadreza Hafezi; Antje Dirlewanger; Lars Grenacher; Markus K Diener; Hamidreza Fonouni; Mohammd Golriz; Camelia Garoussi; Nassim Fard; Nuh N Rahbari; Jens Werner; Markus W Büchler
Journal:  Pancreas       Date:  2014-07       Impact factor: 3.327

Review 4.  Pancreatic endocrine tumors.

Authors:  Kjell Oberg
Journal:  Semin Oncol       Date:  2010-12       Impact factor: 4.929

5.  Malignant insulinoma causing liver metastasis 8 years after the initial surgery: report of a case.

Authors:  N Sata; W Kimura; T Kanazawa; T Muto
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 6.  Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors.

Authors:  David C Metz; Robert T Jensen
Journal:  Gastroenterology       Date:  2008-08-12       Impact factor: 22.682

7.  Malignant insulinoma presenting a non-functioning metastatic liver tumor 14 years after resection of the primary tumor.

Authors:  M Kobayashi; S Kawa; M Kobayashi; Y Imai; T Sodeyama; K Kiyosawa
Journal:  J Gastroenterol       Date:  1998-12       Impact factor: 7.527

Review 8.  Neuroendocrine tumors of the pancreas.

Authors:  Jacek Dadan; Piotr Wojskowicz; Agnieszka Wojskowicz
Journal:  Wiad Lek       Date:  2008

9.  Liver metastases 9 years after removal of a malignant insulinoma which was initially considered benign.

Authors:  Abel Gonzalez-Gonzalez; Jose María Recio-Cordova
Journal:  JOP       Date:  2006-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.